Neuroleptic-induced catatonia: case report.
A case is reported of neuroleptic-induced catatonia that developed after treatment with loxapine succinate, a drug not previously reported to cause catatonia. The syndrome, characterized by marked parkinsonism, episodes of posturing, social withdrawal, and urinary incontinence, persisted during haloperidol treatment and remitted when the drug was discontinued. This syndrome appears to represent severe neuroleptic-induced parkinsonism.
D000293:Adolescent; D002389:Catatonia / Q000139:chemically induced* / Q000175:diagnosis; D003937:Diagnosis, Differential; D003989:Dibenzoxazepines / Q000009:adverse effects*; D006801:Humans; D008152:Loxapine / Q000009:adverse effects*; D008297:Male; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000175:diagnosis; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy; D012560:Schizophrenia, Catatonic / Q000175:diagnosis
D003989:Dibenzoxazepines; D008152:Loxapine